Yongqian Wu Overview
- Investor Type
-
Angel
- Investments
-
1
- Exits
-
1
Yongqian Wu General Information
Description
Dr. Yongqian Wu is an Angel Investor. He served as Chairman & Chief Executive Officer at TransThera Bioscience. He has over 27 years of science and leadership experience in biopharmaceutical companies. Before founding our Company, Dr. Wu was the general manager of Shandong XuanZhu Pharmaceutical. He has more than ten years of research leadership experience at Boehringer Ingelheim Pharmaceuticals Inc. and Guilford Pharmaceuticals Inc. He was a former member of the prestige American Chemistry Society Division of Medicinal Chemistry long range planning committee. He obtained his Ph.D. degree in Medicinal Chemistry from Wayne State University, and his Bachelor degree in Organic Chemistry from Nanjing University.
Business Details
Primary Investor Type
Yongqian Wu Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Educents | 06-Apr-2015 | Recreational Goods | Out of Business |
Yongqian Wu Exits (1)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Educents | 01-Jan-2019 |
Yongqian Wu Investments by Industry, Year, and Region
Yongqian Wu FAQs
-
Who is Yongqian Wu?
Yongqian Wu is an angel Investor who has made 1 investment.
-
What kind of investor is Yongqian Wu?
Yongqian Wu is an angel investor.
-
What does Yongqian Wu do?
As an angel investor, Yongqian Wu invests personal money into promising companies, typically in exchange for equity.
-
What has Yongqian Wu invested in?
Yongqian Wu has invested in Educents within the Recreational Goods industry.
-
What has Yongqian Wu invested in recently?
Yongqian Wu's latest investment was on 06-Apr-2015 in Educents, a company within the Recreational Goods industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »